| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 452 | 441 | 359 | 6 | 0 | 0 | 5 | 1 | 0 | 1 | 0 | 0 | |
Growth YoY Revenue Growth YoY% | 31.4 | 13.5 | -8.8 | -98.6 | -100.0 | -100.0 | -98.5 | -87.6 | -100.0 | 12,800.0 | -91.6 | -98.6 |
| 410 | 393 | 320 | 6 | 0 | 0 | 6 | 0 | 2 | 59 | 28 | 7 | |
| 42 | 49 | 40 | -1 | 0 | 0 | -1 | 1 | -2 | -57 | -27 | -7 | |
OPM OPM% | 9.3 | 11.0 | 11.1 | -10.1 | -400.0 | -400.0 | -16.0 | 76.1 | -4,437.2 | -6,197.7 | -66,800.0 | |
| 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6 | 3 | 14 | |
Interest Expense Interest ExpenseCr | 25 | 24 | 20 | 0 | 0 | 0 | 0 | 0 | 30 | 6 | 0 | 0 |
Depreciation DepreciationCr | 15 | 15 | 15 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 11 | 5 | 0 | 0 | 0 | -1 | 0 | -32 | -57 | -25 | 7 |
| 1 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | -11 | -20 | -9 | 4 | |
| 2 | 1 | 3 | 6 | 8 | -130 | -63 | -176 | 14 | -68 | -15 | 3 | |
Growth YoY PAT Growth YoY% | 116.9 | -84.0 | 63.2 | 449.0 | 399.4 | -22,149.2 | -2,229.0 | -3,243.0 | 82.0 | 47.8 | 75.6 | 101.5 |
NPM NPM% | 0.3 | 0.1 | 0.8 | 97.6 | 78,400.0 | -13,00,900.0 | -1,206.7 | -24,790.1 | -5,265.1 | -3,500.0 | 27,200.0 | |
| 0.1 | 0.0 | 0.1 | 0.3 | 0.3 | -5.8 | -2.8 | -7.8 | 0.6 | -3.4 | -0.8 | 0.1 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 452 | 441 | 359 | 6 | 0 | 0 | 5 | 1 | 0 | 1 | 0 | 0 | |
Growth YoY Revenue Growth YoY% | 31.4 | 13.5 | -8.8 | -98.6 | -100.0 | -100.0 | -98.5 | -87.6 | -100.0 | 12,800.0 | -91.6 | -98.6 |
| 410 | 393 | 320 | 6 | 0 | 0 | 6 | 0 | 2 | 59 | 28 | 7 | |
| 42 | 49 | 40 | -1 | 0 | 0 | -1 | 1 | -2 | -57 | -27 | -7 | |
OPM OPM% | 9.3 | 11.0 | 11.1 | -10.1 | -400.0 | -400.0 | -16.0 | 76.1 | -4,437.2 | -6,197.7 | -66,800.0 | |
| 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6 | 3 | 14 | |
Interest Expense Interest ExpenseCr | 25 | 24 | 20 | 0 | 0 | 0 | 0 | 0 | 30 | 6 | 0 | 0 |
Depreciation DepreciationCr | 15 | 15 | 15 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 11 | 5 | 0 | 0 | 0 | -1 | 0 | -32 | -57 | -25 | 7 |
| 1 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | -11 | -20 | -9 | 4 | |
| 2 | 1 | 3 | 6 | 8 | -130 | -63 | -176 | 14 | -68 | -15 | 3 | |
Growth YoY PAT Growth YoY% | 116.9 | -84.0 | 63.2 | 449.0 | 399.4 | -22,149.2 | -2,229.0 | -3,243.0 | 82.0 | 47.8 | 75.6 | 101.5 |
NPM NPM% | 0.3 | 0.1 | 0.8 | 97.6 | 78,400.0 | -13,00,900.0 | -1,206.7 | -24,790.1 | -5,265.1 | -3,500.0 | 27,200.0 | |
| 0.1 | 0.0 | 0.1 | 0.3 | 0.3 | -5.8 | -2.8 | -7.8 | 0.6 | -3.4 | -0.8 | 0.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 1,676 | 1,644 | 1,876 | 2,783 | 2,366 | 1,543 | 1,669 | 1,524 | 1,684 | 0 | 0 | 2 |
Growth Revenue Growth% | 1.9 | -1.9 | 14.2 | 48.3 | -15.0 | -34.8 | 8.1 | -8.7 | 10.5 | -100.0 | -70.8 | |
| 1,437 | 1,419 | 1,640 | 2,519 | 2,147 | 1,434 | 1,510 | 1,471 | 1,533 | 0 | 61 | 95 | |
| 239 | 224 | 236 | 264 | 220 | 109 | 159 | 53 | 152 | 0 | -61 | -93 | |
OPM OPM% | 14.3 | 13.7 | 12.6 | 9.5 | 9.3 | 7.1 | 9.5 | 3.5 | 9.0 | -5,351.7 | ||
| 6 | 23 | 6 | 6 | 4 | -22 | 11 | 43 | 15 | 2 | 9 | 24 | |
Interest Expense Interest ExpenseCr | 123 | 117 | 115 | 148 | 126 | 112 | 79 | 79 | 87 | 0 | 36 | 36 |
Depreciation DepreciationCr | 57 | 62 | 64 | 63 | 61 | 60 | 57 | 59 | 61 | 1 | 0 | 0 |
PBT PBTCr | 64 | 67 | 63 | 59 | 37 | -85 | 34 | -42 | 18 | 1 | -88 | -106 |
| 10 | 12 | 10 | 11 | 6 | -12 | 9 | -18 | 13 | 0 | -31 | -36 | |
PAT PATCr | 54 | 55 | 52 | 48 | 32 | -73 | 25 | -24 | 5 | 1 | -57 | -66 |
Growth PAT Growth% | -18.1 | 2.0 | -5.5 | -8.9 | -33.2 | -330.5 | 134.2 | -196.6 | 120.7 | -86.0 | -8,327.7 | 81.7 |
NPM NPM% | 3.2 | 3.4 | 2.8 | 1.7 | 1.3 | -4.8 | 1.5 | -1.6 | 0.3 | -3,812.1 | ||
| 2.4 | 2.5 | 2.3 | 2.1 | 1.4 | -3.3 | 1.1 | -1.1 | 0.2 | -5.0 | -13.4 | -3.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 1,676 | 1,644 | 1,876 | 2,783 | 2,366 | 1,543 | 1,669 | 1,524 | 1,684 | 0 | 0 | 2 |
Growth Revenue Growth% | 1.9 | -1.9 | 14.2 | 48.3 | -15.0 | -34.8 | 8.1 | -8.7 | 10.5 | -100.0 | -70.8 | |
| 1,437 | 1,419 | 1,640 | 2,519 | 2,147 | 1,434 | 1,510 | 1,471 | 1,533 | 0 | 61 | 95 | |
| 239 | 224 | 236 | 264 | 220 | 109 | 159 | 53 | 152 | 0 | -61 | -93 | |
OPM OPM% | 14.3 | 13.7 | 12.6 | 9.5 | 9.3 | 7.1 | 9.5 | 3.5 | 9.0 | -5,351.7 | ||
| 6 | 23 | 6 | 6 | 4 | -22 | 11 | 43 | 15 | 2 | 9 | 24 | |
Interest Expense Interest ExpenseCr | 123 | 117 | 115 | 148 | 126 | 112 | 79 | 79 | 87 | 0 | 36 | 36 |
Depreciation DepreciationCr | 57 | 62 | 64 | 63 | 61 | 60 | 57 | 59 | 61 | 1 | 0 | 0 |
PBT PBTCr | 64 | 67 | 63 | 59 | 37 | -85 | 34 | -42 | 18 | 1 | -88 | -106 |
| 10 | 12 | 10 | 11 | 6 | -12 | 9 | -18 | 13 | 0 | -31 | -36 | |
PAT PATCr | 54 | 55 | 52 | 48 | 32 | -73 | 25 | -24 | 5 | 1 | -57 | -66 |
Growth PAT Growth% | -18.1 | 2.0 | -5.5 | -8.9 | -33.2 | -330.5 | 134.2 | -196.6 | 120.7 | -86.0 | -8,327.7 | 81.7 |
NPM NPM% | 3.2 | 3.4 | 2.8 | 1.7 | 1.3 | -4.8 | 1.5 | -1.6 | 0.3 | -3,812.1 | ||
| 2.4 | 2.5 | 2.3 | 2.1 | 1.4 | -3.3 | 1.1 | -1.1 | 0.2 | -5.0 | -13.4 | -3.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 19 | 19 |
Reserves ReservesCr | 932 | 984 | 1,036 | 1,083 | 1,114 | 1,040 | 1,065 | 1,042 | 1,047 | 934 | 563 | 550 |
| 1,240 | 1,279 | 1,309 | 1,300 | 1,248 | 1,187 | 1,004 | 891 | 973 | 1,022 | 26 | 23 | |
| 362 | 296 | 356 | 300 | 249 | 222 | 299 | 234 | 149 | 70 | 13 | 9 | |
| 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 | 622 | 601 | |
| 1,464 | 1,496 | 1,661 | 1,669 | 1,615 | 1,239 | 1,355 | 1,231 | 1,284 | 1,238 | 253 | 263 | |
| 1,092 | 1,085 | 1,063 | 1,036 | 1,018 | 1,232 | 1,036 | 958 | 907 | 810 | 369 | 338 | |
| 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 | 622 | 601 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 19 | 19 |
Reserves ReservesCr | 932 | 984 | 1,036 | 1,083 | 1,114 | 1,040 | 1,065 | 1,042 | 1,047 | 934 | 563 | 550 |
| 1,240 | 1,279 | 1,309 | 1,300 | 1,248 | 1,187 | 1,004 | 891 | 973 | 1,022 | 26 | 23 | |
| 362 | 296 | 356 | 300 | 249 | 222 | 299 | 234 | 149 | 70 | 13 | 9 | |
| 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 | 622 | 601 | |
| 1,464 | 1,496 | 1,661 | 1,669 | 1,615 | 1,239 | 1,355 | 1,231 | 1,284 | 1,238 | 253 | 263 | |
| 1,092 | 1,085 | 1,063 | 1,036 | 1,018 | 1,232 | 1,036 | 958 | 907 | 810 | 369 | 338 | |
| 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 | 622 | 601 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 | 199 | 65 | 239 | 285 | 21 | 95 | 134 | 225 | 169 | -349 | |
| -77 | -18 | -29 | -26 | -33 | -29 | 17 | 52 | -17 | -42 | 1,208 | |
| -89 | -204 | -40 | -201 | -252 | 11 | -119 | -186 | -205 | -128 | -767 | |
Net Cash Flow Net Cash FlowCr | 3 | -23 | -4 | 12 | 0 | 4 | -8 | 0 | 2 | -1 | 93 |
Free Cash Flow Free Cash FlowCr | 87 | 174 | 32 | 204 | 249 | -10 | 110 | 183 | 195 | 126 | -341 |
CFO To PAT CFO To PAT% | 311.2 | 359.2 | 124.7 | 502.6 | 896.4 | -29.2 | 379.3 | -552.7 | 4,498.2 | 24,309.6 | 608.1 |
CFO To EBITDA CFO To EBITDA% | 70.7 | 88.6 | 27.6 | 90.6 | 129.7 | 19.6 | 59.9 | 252.1 | 148.3 | -90,126.6 | 574.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 | 199 | 65 | 239 | 285 | 21 | 95 | 134 | 225 | 169 | -349 | |
| -77 | -18 | -29 | -26 | -33 | -29 | 17 | 52 | -17 | -42 | 1,208 | |
| -89 | -204 | -40 | -201 | -252 | 11 | -119 | -186 | -205 | -128 | -767 | |
Net Cash Flow Net Cash FlowCr | 3 | -23 | -4 | 12 | 0 | 4 | -8 | 0 | 2 | -1 | 93 |
Free Cash Flow Free Cash FlowCr | 87 | 174 | 32 | 204 | 249 | -10 | 110 | 183 | 195 | 126 | -341 |
CFO To PAT CFO To PAT% | 311.2 | 359.2 | 124.7 | 502.6 | 896.4 | -29.2 | 379.3 | -552.7 | 4,498.2 | 24,309.6 | 608.1 |
CFO To EBITDA CFO To EBITDA% | 70.7 | 88.6 | 27.6 | 90.6 | 129.7 | 19.6 | 59.9 | 252.1 | 148.3 | -90,126.6 | 574.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 852 | 789 | 593 | 383 | 222 | 417 | 539 | 356 | 675 | 515 | 181 | 191 |
Price To Earnings Price To Earnings | 15.7 | 14.3 | 11.3 | 8.1 | 7.0 | 21.5 | 136.9 | |||||
Price To Sales Price To Sales | 0.5 | 0.5 | 0.3 | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | 0.4 | 109.5 | ||
Price To Book Price To Book | 0.9 | 0.8 | 0.6 | 0.3 | 0.2 | 0.4 | 0.5 | 0.3 | 0.6 | 0.5 | 0.3 | 0.3 |
EV To EBITDA EV To EBITDA | 7.1 | 7.0 | 6.1 | 4.4 | 4.3 | 11.3 | 8.7 | 20.6 | 8.5 | -5,734.8 | -1.1 | -0.8 |
GPM GPM% | 22.4 | 22.0 | 19.5 | 14.8 | 15.6 | 16.7 | 17.9 | 12.6 | 17.6 | |||
OPM OPM% | 14.3 | 13.7 | 12.6 | 9.5 | 9.3 | 7.1 | 9.5 | 3.5 | 9.0 | -5,351.7 | ||
NPM NPM% | 3.2 | 3.4 | 2.8 | 1.7 | 1.3 | -4.8 | 1.5 | -1.6 | 0.3 | -3,812.1 | ||
ROCE ROCE% | 10.2 | 10.3 | 9.3 | 10.8 | 8.7 | 1.4 | 5.8 | 2.0 | 6.2 | 0.1 | -8.9 | -12.2 |
ROE ROE% | 5.7 | 5.5 | 4.9 | 4.3 | 2.8 | -6.9 | 2.3 | -2.3 | 0.5 | 0.1 | -9.8 | -11.6 |
ROA ROA% | 2.1 | 2.1 | 1.9 | 1.8 | 1.2 | -3.0 | 1.1 | -1.1 | 0.2 | 0.0 | -9.2 | -11.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 852 | 789 | 593 | 383 | 222 | 417 | 539 | 356 | 675 | 515 | 181 | 191 |
Price To Earnings Price To Earnings | 15.7 | 14.3 | 11.3 | 8.1 | 7.0 | 21.5 | 136.9 | |||||
Price To Sales Price To Sales | 0.5 | 0.5 | 0.3 | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | 0.4 | 109.5 | ||
Price To Book Price To Book | 0.9 | 0.8 | 0.6 | 0.3 | 0.2 | 0.4 | 0.5 | 0.3 | 0.6 | 0.5 | 0.3 | 0.3 |
EV To EBITDA EV To EBITDA | 7.1 | 7.0 | 6.1 | 4.4 | 4.3 | 11.3 | 8.7 | 20.6 | 8.5 | -5,734.8 | -1.1 | -0.8 |
GPM GPM% | 22.4 | 22.0 | 19.5 | 14.8 | 15.6 | 16.7 | 17.9 | 12.6 | 17.6 | |||
OPM OPM% | 14.3 | 13.7 | 12.6 | 9.5 | 9.3 | 7.1 | 9.5 | 3.5 | 9.0 | -5,351.7 | ||
NPM NPM% | 3.2 | 3.4 | 2.8 | 1.7 | 1.3 | -4.8 | 1.5 | -1.6 | 0.3 | -3,812.1 | ||
ROCE ROCE% | 10.2 | 10.3 | 9.3 | 10.8 | 8.7 | 1.4 | 5.8 | 2.0 | 6.2 | 0.1 | -8.9 | -12.2 |
ROE ROE% | 5.7 | 5.5 | 4.9 | 4.3 | 2.8 | -6.9 | 2.3 | -2.3 | 0.5 | 0.1 | -9.8 | -11.6 |
ROA ROA% | 2.1 | 2.1 | 1.9 | 1.8 | 1.2 | -3.0 | 1.1 | -1.1 | 0.2 | 0.0 | -9.2 | -11.0 |
| Market CapitalizationMkt CapCr | 515 | 487 | 257 | 191 | 163 | 44 | 37 |
| Close PriceClose₹ | 94.91 | 1,610.80 | 58.67 | 9.81 | 30.46 | 27.55 | 117.95 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 31.74 | 37.59 | 6.78 | 21.60 | 9.64 | ||
| Price To SalesPS | 1.37 | 1.46 | 0.65 | 109.52 | 0.28 | 0.17 | 1.24 |
| RevenueRevenueCr | 377 | 334 | 395 | 2 | 583 | 262 | 30 |
| Revenue Growth TTMRev Gr TTM% | 102.4% | -1.0% | -70.8% | 42.4% | -2.3% | -8.0% | |
| PAT Growth TTMPAT Gr TTM% | 219.7% | -44.7% | 81.7% | 35.8% | -92.5% | -14.1% |
| Market CapitalizationMkt CapCr | 515 | 487 | 257 | 191 | 163 | 44 | 37 |
| Close PriceClose₹ | 94.91 | 1,610.80 | 58.67 | 9.81 | 30.46 | 27.55 | 117.95 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 31.74 | 37.59 | 6.78 | 21.60 | 9.64 | ||
| Price To SalesPS | 1.37 | 1.46 | 0.65 | 109.52 | 0.28 | 0.17 | 1.24 |
| RevenueRevenueCr | 377 | 334 | 395 | 2 | 583 | 262 | 30 |
| Revenue Growth TTMRev Gr TTM% | 102.4% | -1.0% | -70.8% | 42.4% | -2.3% | -8.0% | |
| PAT Growth TTMPAT Gr TTM% | 219.7% | -44.7% | 81.7% | 35.8% | -92.5% | -14.1% |